These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2690329)
1. Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Olbe L; Cederberg C; Lind T; Olausson M Scand J Gastroenterol Suppl; 1989; 166():27-32; discussion 41-2. PubMed ID: 2690329 [TBL] [Abstract][Full Text] [Related]
2. Effect of omeprazole on gastric acid secretion and plasma gastrin. Olbe L; Cederberg C; Lind T; Olausson M J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358 [TBL] [Abstract][Full Text] [Related]
3. 24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients. Lind T; Cederberg C; Olausson M; Olbe L Gastroenterology; 1990 Dec; 99(6):1593-8. PubMed ID: 2227275 [TBL] [Abstract][Full Text] [Related]
4. Effect of omeprazole on gastric acid secretion in man. Olbe L; Lind T; Cederberg C; Ekenved G Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164 [TBL] [Abstract][Full Text] [Related]
5. Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin. Lind T; Cederberg C; Olausson M; Olbe L Eur J Clin Pharmacol; 1991; 40(6):557-60. PubMed ID: 1884735 [TBL] [Abstract][Full Text] [Related]
6. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Lind T; Cederberg C; Forssell H; Olausson M; Olbe L Scand J Gastroenterol; 1988 Dec; 23(10):1259-66. PubMed ID: 3249924 [TBL] [Abstract][Full Text] [Related]
7. Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humans. Karnes WE; Berlin RG; Maxwell V; Sytnik B; Root JK; Walsh JH Aliment Pharmacol Ther; 1990 Oct; 4(5):443-56. PubMed ID: 2129633 [TBL] [Abstract][Full Text] [Related]
8. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Hurlimann S; Abbühl B; Inauen W; Halter F Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351 [TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Lanzon-Miller S; Pounder RE; Hamilton MR; Ball S; Chronos NA; Raymond F; Olausson M; Cederberg C Aliment Pharmacol Ther; 1987 Jun; 1(3):239-51. PubMed ID: 2979226 [TBL] [Abstract][Full Text] [Related]
10. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients. Lazzaroni M; Sangaletti O; Bianchi Porro G Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586 [TBL] [Abstract][Full Text] [Related]
11. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061 [TBL] [Abstract][Full Text] [Related]
12. Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients. Hewson EG; Yeomans ND; Angus PW; Shulkes A; Brook CW; Sewell RB; Smallwood RA Gut; 1988 Dec; 29(12):1715-20. PubMed ID: 3220312 [TBL] [Abstract][Full Text] [Related]
13. Omeprazole: a novel antisecretory agent for the treatment of acid-peptic disorders. Lampkin TA; Ouellet D; Hak LJ; Dukes GE DICP; 1990 Apr; 24(4):393-402. PubMed ID: 2183494 [TBL] [Abstract][Full Text] [Related]
14. Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats. Ryberg B; Mattsson H; Carlsson E Digestion; 1988; 39(2):91-9. PubMed ID: 3410171 [TBL] [Abstract][Full Text] [Related]
15. Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients. Tari A; Hamada M; Kamiyasu T; Fukino Y; Sumii M; Haruma K; Sumii K; Inoue M; Kajiyama G J Gastroenterol; 1996 Apr; 31(2):167-70. PubMed ID: 8680534 [TBL] [Abstract][Full Text] [Related]
16. Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer. Howden CW; Derodra JK; Burget DW; Hunt RH Hepatogastroenterology; 1986 Dec; 33(6):267-70. PubMed ID: 3804185 [TBL] [Abstract][Full Text] [Related]
17. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease. Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051 [TBL] [Abstract][Full Text] [Related]
18. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion. Biemond I; Crobach LF; Jansen JB; Lamers CB Eur J Clin Pharmacol; 1989; 37(4):345-9. PubMed ID: 2598968 [TBL] [Abstract][Full Text] [Related]
19. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox. Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Zak J Am J Med; 1991 Aug; 91(2A):91S-94S. PubMed ID: 1882910 [TBL] [Abstract][Full Text] [Related]
20. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Prewett EJ; Hudson M; Nwokolo CU; Sawyerr AM; Pounder RE Gastroenterology; 1991 Apr; 100(4):873-7. PubMed ID: 2001826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]